| Issue Date | Title | Author(s) |
| 2019-09 | Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity. | Goel, S; Liu, J; Guo, H; Barry, W; Bell, R; Murray, B; Lynch, J; Bastick, P; Chantrill, L; Kiely, BE; Abdi, E; Rutovitz, J; Asghari, R; Sullivan, A; Harrison, M; Kohonen-Corish, M; Beith, J |
| 2024-11-08 | DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol. | White, C; Wardill, H; Paul, C; Price, T; Karapetis, C; Nalder, M; Burge, ME; Thomas, A; Oldmeadow, C; Barker, D; Edney, LC; Coller, J; Bowen, J; Ostroff, C; Cheek, B; Carlson, M; Rankmore, T; Nagrial, A; Clarke, S; Chantrill, L; Ackland, S; Scott, RJ |
| 2019-04 | Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. | Maharaj, AD; Ioannou, L; Croagh, D; Zalcberg, J; Neale, RE; Goldstein, D; Merrett, N; Kench, JG; White, K; Pilgrim, CHC; Chantrill, L; Cosman, P; Kneebone, A; Lipton, L; Nikfarjam, M; Philip, J; Sandroussi, C; Tagkalidis, P; Chye, R; Haghighi, KS; Samra, J; Evans, SM |
| 2022-08 | Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer. | Gugusheff, J; White, K; Fitzadam, S; Creighton, N; Engel, A; Lee, M; Thompson, SR; Chantrill, L; Young, J; Currow, D |
| 2018-11-30 | ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. | Pinho, AV; Van Bulck, M; Chantrill, L; Arshi, M; Sklyarova, T; Herrmann, D; Vennin, C; Gallego-Ortega, D; Mawson, A; Giry-Laterriere, M; Magenau, A; Leuckx, G; Baeyens, L; Gill, AJ; Phillips, P; Timpson, P; Biankin, AV; Wu, J; Rooman, I |
| 2018-11-01 | ROBO2 is a Stroma Suppressor Gene in the Pancreas Through Regulation of TGF-beta | Pinho, AV; Bulck, MV; Chantrill, L; Arshi, M; Sklyarova, T; Herrmann, D; Vennin, C; Gallego-Ortega, D; Mawson, A; Giry-Laterriere, M; Magenau, A; Baeyens, L; Gill, AJ; Phillips, P; Timpson, P; Biankin, AV; Wu, J; Rooman, I |
| 2017-04-05 | Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. | Vennin, C; Chin, VT; Warren, SC; Lucas, MC; Herrmann, D; Magenau, A; Melenec, P; Walters, SN; Del Monte-Nieto, G; Conway, JRW; Nobis, M; Allam, AH; McCloy, RA; Currey, N; Pinese, M; Boulghourjian, A; Zaratzian, A; Adam, AAS; Heu, C; Nagrial, AM; Chou, A; Steinmann, A; Drury, A; Froio, D; Giry-Laterriere, M; Harris, NLE; Phan, T; Jain, R; Weninger, W; McGhee, EJ; Whan, R; Johns, AL; Samra, JS; Chantrill, L; Gill, AJ; Kohonen-Corish, M; Harvey, RP; Biankin, AV; Australian Pancreatic Cancer Genome Initiative (APGI),; Evans, TRJ; Anderson, KI; Grey, ST; Ormandy, CJ; Gallego-Ortega, D; Wang, Y; Samuel, MS; Sansom, OJ; Burgess, A; Cox, TR; Morton, JP; Pajic, M; Timpson, P |
